Loading...
•
Oct 31, 2020
Cooper Q4 2020 Earnings Report
CooperCompanies announced its financial results for the fourth quarter and full year of 2020.
Key Takeaways
CooperCompanies reported a decrease in revenue by 1% year-over-year to $681.6 million. The GAAP diluted EPS was $1.64, a decrease of 32% from the previous year's fourth quarter, while the non-GAAP diluted EPS was $3.16, down by 4%.
Fourth quarter revenue decreased 1% year-over-year to $681.6 million.
CooperVision (CVI) revenue was down 1% to $506.3 million.
CooperSurgical (CSI) revenue was down 4% to $175.3 million.
Fourth quarter GAAP diluted earnings per share (EPS) was $1.64, down 32% from last year's fourth quarter.
Cooper
Cooper
Cooper Revenue by Segment
Cooper Revenue by Geographic Location
Revenue by Segment
Office & Surgical Revenue
CapyFin.comFertility Revenue
CapyFin.comRevenue by Geographic Location
Americas Revenue
CapyFin.comEMEA Revenue
CapyFin.comAsia Pacific Revenue
CapyFin.com Forward Guidance
Given the uncertain scope and duration of the ongoing COVID-19 pandemic, the company is unable to provide formal financial guidance for fiscal year 2021. Fiscal first quarter 2021 guidance is summarized as follows:
Positive Outlook
- Fiscal first quarter 2021 total revenue $642 - $670 million (down 3% to up 2% constant currency)
- CVI revenue $482 - $502 million (down 3% to up 1% constant currency)
- CSI revenue $160 - $168 million (down 1% to up 4% constant currency)
- Fiscal first quarter 2021 non-GAAP diluted earnings per share $2.66 - $2.86
Revenue & Expenses
Visualization of income flow from segment revenue to net income